Porgaviximab (anti-EBOV) is a monoclonal antibody that can be used Ebola infection research. Purity ≥95% (SDS-PAGE&SEC) Endotoxin Level < 1.0EU/mg
Product Properties
Isotype
Human IgG1
Light Chain Type
kappa
SDS-PAGE
25.8 kDa (Light Chain) & 51.8 kDa (Heavy Chain), under reducing conditions; 196.1 kDa, under non-reducing conditions.
Purification Method
Protein A purified
Form
Liquid
Concentration
See COA
Storage Temp
Store at -80°C,Avoid repeated freezing and thawing
Shipped In
Ice chest + Ice pads
Stability And Storage
Store at -80℃ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle.
CAS
1792982-55-8
Images
Porgaviximab (anti-EBOV) (Ab182767) - SEC The purity of Porgaviximab (anti-EBOV) (Ab182767) is more than 95% verified by HPLC.
Porgaviximab (anti-EBOV) (Ab182767) - ELISA Immobilized EBOV (subtype Zaire) GP Protein (His Tag) at 2.0 μg/mL can bind Porgaviximab (anti-EBOV) (Ab182767) with the EC₅₀ of 12.12 ng/mL.
Certificates
Certificate of Analysis(COA)
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
ZJ24F0505662